Invesco Ltd. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,785,458
+22.5%
946,429
+0.0%
0.01%
+16.7%
Q2 2023$21,048,144
-11.1%
945,984
-13.5%
0.01%
-14.3%
Q1 2023$23,678,994
+17.3%
1,093,213
+10.0%
0.01%
+16.7%
Q4 2022$20,180,077
-14.5%
993,603
+8.0%
0.01%
-25.0%
Q3 2022$23,600,000
-18.7%
920,425
-24.6%
0.01%
-11.1%
Q2 2022$29,012,000
+19.1%
1,220,031
+12.8%
0.01%
+50.0%
Q1 2022$24,355,000
+13.8%
1,081,463
+0.0%
0.01%
+20.0%
Q4 2021$21,409,000
-23.7%
1,081,291
-24.1%
0.01%
-28.6%
Q3 2021$28,055,000
+0.6%
1,425,555
+12.4%
0.01%0.0%
Q2 2021$27,896,000
+2.6%
1,268,033
+11.0%
0.01%0.0%
Q1 2021$27,185,000
-8.3%
1,142,654
+0.8%
0.01%
-22.2%
Q4 2020$29,642,000
-26.6%
1,133,093
-51.1%
0.01%
-35.7%
Q3 2020$40,362,000
+77.8%
2,318,995
+71.9%
0.01%
+75.0%
Q2 2020$22,695,000
+39.7%
1,349,240
-1.2%
0.01%
+14.3%
Q1 2020$16,241,000
-31.2%
1,365,987
-30.0%
0.01%0.0%
Q4 2019$23,596,000
+17.9%
1,950,076
+37.8%
0.01%
+40.0%
Q3 2019$20,009,000
-1.7%
1,415,512
-22.5%
0.01%0.0%
Q2 2019$20,353,000
-19.6%
1,825,412
-15.4%
0.01%
-44.4%
Q1 2019$25,319,000
-13.3%
2,156,696
-1.3%
0.01%
-18.2%
Q4 2018$29,207,000
-25.1%
2,186,096
-21.4%
0.01%
-8.3%
Q3 2018$38,999,000
+35.9%
2,781,681
+52.3%
0.01%
+33.3%
Q2 2018$28,703,000
+13.5%
1,825,935
+18.8%
0.01%0.0%
Q1 2018$25,278,000
-29.3%
1,536,670
-22.4%
0.01%
-30.8%
Q4 2017$35,747,000
-6.7%
1,979,269
-0.3%
0.01%
-7.1%
Q3 2017$38,323,000
+36.1%
1,985,651
-16.8%
0.01%
+55.6%
Q2 2017$28,167,000
+94.9%
2,387,031
+81.1%
0.01%
+80.0%
Q1 2017$14,449,000
+48.3%
1,318,312
-1.8%
0.01%
+66.7%
Q4 2016$9,742,000
+3.6%
1,341,991
-7.2%
0.00%0.0%
Q3 2016$9,404,000
+28.7%
1,446,873
+8.1%
0.00%0.0%
Q2 2016$7,306,000
+721.8%
1,338,010
+604.5%
0.00%
Q1 2016$889,000
+1039.7%
189,912
+1105.1%
0.00%
Q4 2015$78,000
-94.6%
15,759
-93.4%
0.00%
-100.0%
Q2 2015$1,441,000
-7.8%
239,784
-14.1%
0.00%0.0%
Q1 2015$1,563,000279,1710.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders